Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine

Documenti analoghi

• Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens
  di: Vassilakopoulos, Theodoros P., et al.
  Pubblicazione: (2016)
• Very Low Utility of Surveillance Imaging in Early-Stage Classic Hodgkin Lymphoma Treated With a Combination of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Radiation Therapy
  di: Gandikota, Neetha, et al.
  Pubblicazione: (2015)
• HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era
  di: Montoto, Silvia, et al.
  Pubblicazione: (2012)
• Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy
  di: Lee, Suk-young, et al.
  Pubblicazione: (2012)
• Methotrexate-associated Hodgkin Lymphoma in a Patient with Rheumatoid Arthritis Successfully Treated with Brentuximab Vedotin in Combination with Doxorubicin, Vinblastine, and Dacarbazine (BV+AVD)
  di: Sekiguchi, Yasunobu, et al.
  Pubblicazione: (2020)